 | • レポートコード：MRC2303G018 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界の自動体外式除細動器（AED）市場規模が、年度末に717.52百万ドルに及び、予測期間中、CAGR 9.4％で増加すると推測されています。本書では、自動体外式除細動器（AED）の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、分析種類別（半自動体外式除細動器（AED）、完全自動体外式除細動器（AED））分析、エンドユーザー別（病院・診療所、在宅医療、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、Asahi Kasei Corporation、Koninklijke Philips NV、Nihon Kohden Corporation、Schiller AG、Shenzhen Mindray Bio-Medical Electronics Co. Ltdなどが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の自動体外式除細動器（AED）市場規模：分析種類別 - 半自動体外式除細動器（AED）の市場規模 - 完全自動体外式除細動器（AED）の市場規模 ・世界の自動体外式除細動器（AED）市場規模：エンドユーザー別 - 病院・診療所における市場規模 - 在宅医療における市場規模 - その他エンドユーザーにおける市場規模 ・世界の自動体外式除細動器（AED）市場規模：地域別 - 北米の自動体外式除細動器（AED）市場規模 アメリカの自動体外式除細動器（AED）市場規模 カナダの自動体外式除細動器（AED）市場規模 メキシコの自動体外式除細動器（AED）市場規模 … - ヨーロッパの自動体外式除細動器（AED）市場規模 ドイツの自動体外式除細動器（AED）市場規模 イギリスの自動体外式除細動器（AED）市場規模 フランスの自動体外式除細動器（AED）市場規模 … - アジア太平洋の自動体外式除細動器（AED）市場規模 中国の自動体外式除細動器（AED）市場規模 日本の自動体外式除細動器（AED）市場規模 インドの自動体外式除細動器（AED）市場規模 … - 南米/中東の自動体外式除細動器（AED）市場規模 ブラジルの自動体外式除細動器（AED）市場規模 アルゼンチンの自動体外式除細動器（AED）市場規模 サウジアラビアの自動体外式除細動器（AED）市場規模 … ・競争状況 ・市場機会・将来動向 |
The global automated external defibrillator market was valued at USD 717.52 million during the base year, and it is projected to register a CAGR of 9.4% during the forecast period.
The COVID-19 pandemic had a significant impact on the growth of the market. This was due to the postponement of cardiovascular surgeries and the reduction in the cardiac surgery volume due to the strict regulations imposed by various governments during the pandemic. According to the NCBI article published in July 2021, there was a 52.7% reduction in adult cardiac surgery volume in the United States during the first half of 2020. Such a reduction in cardiac surgeries impacts the demand for an automated external defibrillator used in cardiac procedures. However, the resumption of cardiac surgical procedures during the post-pandemic period is expected to regain the demand for automated external defibrillators, thereby contributing to the market’s growth over the next five years.
The major factors driving the automated electronic defibrillator market growth include the increasing prevalence of cardiac diseases, the rising geriatric population, and technological advancements in the field, supported by increasing investments from market players.
According to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people live with heart or circulatory disease in 2021. Such increasing prevalence of cardiovascular diseases led to an increasing need for automated external defibrillators. Such patient conditions are expected to drive the growth of the market over the forecast period.
Also, the rising number of cardiovascular patients who needed surgical procedures is expected to contribute to the demand for an automated external defibrillator, thereby boosting the growth of the market. According to British Heart Foundation data, published in January 2022, nearly 284,000 people were waiting for time-critical heart operations and other heart procedures at the end of November 2021. Such an increasing number of cardiovascular surgeries generates a need for automated external defibrillators, thus driving the market’s growth.
Moreover, the technological advancement in the field and the rising support by various governments boosts the market’s growth. For instance, in March 2021, the Government House in Australia launched the St. John-branded public access defibrillator, an automated external defibrillator (AED). The AED was a joint venture between St John Ambulance Australia and Zoll Medical Australia.
Thus, the automated external defibrillators market is expected to show lucrative growth over the forecast period owing to the rising burden of cardiovascular diseases and increasing launch of advanced automated external defibrillators. However, factors such as stringent regulations and lack of awareness and early corrective measures about sudden cardiac arrest may hinder the growth of the studied market over the forecast period.
Automated External Defibrillator Market Trends
Fully automated External Defibrillators is Expected to Hold a Significant Share in the Market Over the Forecast Period
The rising prevalence of cardiac diseases across different age groups due to stressful work conditions, sedentary lifestyles, growing consumption of tobacco and alcohol, and substance abuse is expected to drive the growth of the fully automated external defibrillator segment over the forecast period.
According to the BMJ article published in August 2021, around 80% of the study participants diagnosed with atrial fibrillation in the United kingdom population were eligible for early rhythm control. Such a growing burden of arrhythmia creates demand for the automated external defibrillator and is expected to drive the growth of the studied segment over the forecast period. Also, the rising geriatric population is expected to contribute to the growth of the studied segment. As per the UN report published in 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. Such an increase in the geriatric population prone to develop cardiovascular diseases is expected to contribute to the growth of the studied segment over the forecast period.
Also, the increasing product launches are expected to contribute to the segment’s growth over the forecast period. For instance, in October 2021, CellAED launched the handheld, smart personal Automated external defibrillator, which is available for pre-order in Europe.
Thus, the factors such as the rising geriatric population and increasing prevalence of cardiovascular diseases along with the launch of advanced fully automated external defibrillators contribute to the growth of the studied segment over the forecast period.
North America is Expected to Hold a Major Market Share Over the Forecast Period
The North American automated external defibrillators market is expected to grow during the forecast period due to the high burden and increasing prevalence of cardiovascular diseases, new product launches, and the emerging number of key market players in the region.
Additionally, the rising geriatric population is also expected to drive the growth of the market in North American countries. For instance, the data published by Statistics Canada in August 2022 indicated that the population aged 70 to 74 years in Canada was 1,847,585 whereas the population aged 80 to 84 years was 840,545. Such a rise in the geriatric population who are prone to developing cardiovascular diseases is expected to drive the demand for automated external defibrillators, thereby contributing to the growth of the market.
Additionally, the increasing awareness campaigns regarding automated external defibrillators, product approvals, and product launches are expected to reinforce growth prospects over the forecast period in the North American region. For instance, in August 2022, Great Western Air Ambulance Charity launched an event to teach CPR and automated external defibrillator usage. This event coincided with the unveiling of a public-access defibrillator.
Similarly, in August 2021, Kestra Medical Technologies, Inc. received United States FDA premarket approval for the Assure wearable cardioverter defibrillator (WCD) system. This ASSURE WCD system represents the next generation of monitoring and therapy to protect patients at risk of sudden cardiac death.
Thus, the factors such as the increasing prevalence of cardiovascular diseases, the presence of major market players along with frequent product launches are expected to contribute to the growth of the market in this region over the forecast period.
Automated External Defibrillator Market Competitor Analysis
The automated external defibrillator market is moderately competitive, with the presence of a few major players like Asahi Kasei Corporation, Koninklijke Philips NV, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Schiller AG, Stryker Corporation, CU Medical System Inc., Mediana Co. Ltd, BPL Medical Technologies Pvt. Ltd, ViVest Medical, and Others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Cardiovascular Diseases
4.2.2 Technological Advancements in the Field of Defibrillators
4.2.3 Increasing Investments by Private Players
4.3 Market Restraints
4.3.1 Stringent Regulations
4.3.2 Lack of Awareness and Early Corrective Measures about Sudden Cardiac Arrest (SAC)
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Analysis Type
5.1.1 Semi-automated External Defibrillators
5.1.2 Fully-automated External Defibrillators
5.2 By End User
5.2.1 Hospitals/Clinics
5.2.2 Home Care
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 Koninklijke Philips NV
6.1.3 Nihon Kohden Corporation
6.1.4 Schiller AG
6.1.5 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
6.1.6 Stryker Corporation
6.1.7 CU Medical System Inc.
6.1.8 Mediana Co. Ltd
6.1.9 BPL Medical Technologies Pvt. Ltd
6.1.10 Progetti Srl
6.1.11 Bexen Cardio
6.1.12 Corplus
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
